Jiayuh Lin

10.3k total citations · 1 hit paper
137 papers, 8.6k citations indexed

About

Jiayuh Lin is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiayuh Lin has authored 137 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 78 papers in Molecular Biology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Jiayuh Lin's work include Cytokine Signaling Pathways and Interactions (85 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Mechanisms and Therapy (25 papers). Jiayuh Lin is often cited by papers focused on Cytokine Signaling Pathways and Interactions (85 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Mechanisms and Therapy (25 papers). Jiayuh Lin collaborates with scholars based in United States, China and Taiwan. Jiayuh Lin's co-authors include Arnold J. Levine, Chenglong Li, Pui‐Kai Li, Li Lin, Hui Song, Jiandong Chen, Brian Elenbaas, James R. Fuchs, Shaomeng Wang and Melinda Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Jiayuh Lin

131 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

1994 561 citations Jiayuh Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiayuh Lin United States	55	5.3k	4.9k	1.3k	1.3k	1.2k	137	8.6k
Yiwei Li United States	55	3.9k 0.7×	7.0k 1.4×	1.4k 1.1×	3.6k 2.8×	1.2k 1.0×	135	11.3k
Linda S. Steelman United States	49	3.3k 0.6×	7.5k 1.5×	1.2k 0.9×	1.9k 1.4×	990 0.8×	112	11.2k
Shi‐Yong Sun United States	56	2.7k 0.5×	7.2k 1.5×	767 0.6×	1.5k 1.1×	1.2k 1.0×	203	9.5k
Robert W. Robey United States	62	9.2k 1.7×	7.3k 1.5×	627 0.5×	1.2k 0.9×	565 0.5×	159	13.8k
Liwu Fu China	53	4.9k 0.9×	5.4k 1.1×	579 0.4×	1.4k 1.1×	751 0.6×	209	9.9k
Paul J. Chiao United States	60	3.7k 0.7×	7.1k 1.5×	654 0.5×	4.0k 3.1×	2.0k 1.8×	135	11.2k
Dejuan Kong United States	50	3.1k 0.6×	6.2k 1.3×	596 0.5×	3.6k 2.8×	546 0.5×	100	9.0k
Fengzhi Li United States	45	3.2k 0.6×	6.9k 1.4×	445 0.3×	1.1k 0.9×	1.5k 1.3×	139	9.1k
Peter T. Daniel Germany	53	2.8k 0.5×	5.2k 1.1×	652 0.5×	1.0k 0.8×	1.8k 1.6×	135	8.2k
James Turkson United States	47	9.5k 1.8×	7.9k 1.6×	2.9k 2.3×	2.5k 1.9×	3.2k 2.7×	109	15.5k

Countries citing papers authored by Jiayuh Lin

Since Specialization

Citations

This map shows the geographic impact of Jiayuh Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayuh Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayuh Lin more than expected).

Fields of papers citing papers by Jiayuh Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayuh Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayuh Lin. The network helps show where Jiayuh Lin may publish in the future.

Co-authorship network of co-authors of Jiayuh Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayuh Lin. A scholar is included among the top collaborators of Jiayuh Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayuh Lin. Jiayuh Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jie, et al.. (2024). CDK4/6 inhibitors in lung cancer: current practice and future directions. European Respiratory Review. 33(171). 230145–230145. 19 indexed citations

Lo, Hui‐Wen, et al.. (2024). Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling. Current Oncology. 31(10). 5737–5751. 6 indexed citations

Yang, Lehe, et al.. (2019). Novel activators and small-molecule inhibitors of STAT3 in cancer. Cytokine & Growth Factor Reviews. 49. 10–22. 98 indexed citations

Yu, Wenying, Chenglong Li, Wenda Zhang, et al.. (2017). Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking. Journal of Medicinal Chemistry. 60(7). 2718–2731. 41 indexed citations

Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations

Li, Ling, Wenhua Tang, Xiaoqing Wu, et al.. (2013). HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s. Clinical Cancer Research. 19(24). 6703–6715. 57 indexed citations

Bid, Hemant K., Ryan D. Roberts, Maren Cam, et al.. (2013). ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis. Cancer Research. 74(1). 320–329. 47 indexed citations

Lin, Li, Brian Hutzen, Zhengang Peng, et al.. (2013). Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells. PLoS ONE. 8(12). e82821–e82821. 60 indexed citations

Bear, Misty D., et al.. (2012). Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines. BMC Veterinary Research. 8(1). 244–244. 18 indexed citations

10.

Lin, Li, Aiguo Liu, Zhengang Peng, et al.. (2011). STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells. Cancer Research. 71(23). 7226–7237. 251 indexed citations

11.

Liu, Yan, Aiguo Liu, Huameng Li, Chenglong Li, & Jiayuh Lin. (2011). Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells. Cancer Prevention Research. 4(8). 1296–1305. 54 indexed citations

12.

Liu, Aiguo, Yan Liu, Pui‐Kai Li, Chenglong Li, & Jiayuh Lin. (2011). LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.. PubMed. 31(6). 2029–35. 27 indexed citations

13.

Liu, Aiguo, Yan Liu, Zhenghu Xu, et al.. (2011). Novel small molecule, XZH‐5, inhibits constitutive and interleukin‐6‐induced STAT3 phosphorylation in human rhabdomyosarcoma cells. Cancer Science. 102(7). 1381–1387. 23 indexed citations

14.

Lin, Li, Brian Hutzen, Mingxin Zuo, et al.. (2010). Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells. Cancer Research. 70(6). 2445–2454. 197 indexed citations

15.

Liu, Yan, James R. Fuchs, Chenglong Li, & Jiayuh Lin. (2010). IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle. 9(17). 3423–3427. 62 indexed citations

16.

Fuh, Beng, Matthew Sobo, Brian Hutzen, et al.. (2009). LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. British Journal of Cancer. 100(1). 106–112. 75 indexed citations

17.

Ball, Sarah, et al.. (2007). Paracrine signaling from the breast cancer cells stimulates the cell proliferation and Stat3 phosphorylation in non-cancerous mammary epithelial cells and is blocked by dietary agent, curcumin.. Cancer Epidemiology and Prevention Biomarkers. 16. 2 indexed citations

18.

Jin, Xingyi, Dana R. Gossett, Shaomeng Wang, et al.. (2004). Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells. British Journal of Cancer. 91(10). 1808–1812. 62 indexed citations

19.

Gossett, Dana R., Megan S. Bradley, Xiaohong Jin, & Jiayuh Lin. (2004). 17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types. Gynecologic Oncology. 96(2). 381–388. 18 indexed citations

20.

Lin, Jiayuh, et al.. (1996). Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities. Molecular and Cellular Biology. 16(4). 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact